CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 447 enrolled
Drug / intervention
Nebulized 3% saline +1 moredrug
Likely dose
Nebulized 3% saline 4 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00619918
NCT00619918Phase 3Completed
CompareCT.gov

Nebulized Hypertonic Saline for Treatment of Viral Bronchiolitis

Children's Hospital Los Angeles·interventional·Posted Feb 21, 2008·Updated Nov 5, 2024

In Brief

A Phase 3 clinical trial evaluating Nebulized 3% saline and Nebulized 0.9% saline for Bronchiolitis. Completed, enrolled 447 participants across 2 sites.

Detailed Summary

This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis
CountriesUnited States
CollaboratorsUCSF Benioff Children's Hospital Oakland, Thrasher Research Fund

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 21, 2008
Enrollment StartFeb 1, 2008
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 18.4 years ago

Interventions

Nebulized 3% salinedrug

4 ml inhaled q8h

Nebulized 0.9% salinedrug

normal saline